Ginkgo Bioworks Holdings, Inc. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 54.18M76.66M313.84M477.71M251.46M227.04M
Cost of Revenue 8.91M129.69M183.57M46.52M38.55M
Gross Profit 54.18M-123.44M-122.05M-298.28M204.93M188.49M
Operating items
Research & Development 96.30M159.77M1149.66M1052.64M580.62M424.06M
Selling, General & Administrative 29.48M38.31M862.95M1429.80M385.02M246.16M
Other Operating Expenses 1.57M7.84M-1.73M7.63M9.14M3.87M
Operating Expenses 125.78M213.68M2142.30M2686.66M1115.86M786.80M
Operating Income -71.60M-137.03M-1828.47M-2208.95M-864.41M-559.76M
EBIT -71.60M-137.03M-1828.47M-2208.95M-864.41M-559.76M
Non-operating items
Non Operating Investment Income -27.20M-3.73M-11.54M-53.34M-54.83M-28.83M
Interest & Investment Income 5.76M2.58M0.84M20.26M57.22M38.61M
Other Non Operating Income 12.19M-9.65M87.55M-28.53M12.25M
Non Operating Income 12.19M-9.65M87.55M-28.53M12.25M
Net income details
EBT -119.83M-124.83M-1838.12M-2121.40M-892.94M-547.51M
Tax Provisions 0.02M1.89M-1.48M-15.03M-0.07M-0.48M
Profit After Tax -119.86M-126.72M-1836.64M-2106.37M-892.87M-547.03M
Equity Income -27.53M-0.40M-77.28M-43.76M-2.63M
Income from Non-Controlling Interests -0.53M-0.11M-6.59M-1.44M
Income from Continuing Operations -119.86M-126.72M-1836.64M-2106.37M-892.87M-547.03M
Consolidated Net Income -119.86M-126.72M-1836.64M-2106.37M-892.87M-547.03M
Income towards Parent Company -119.86M-126.72M-1836.64M-2106.37M-892.87M-547.03M
Net Income towards Common Stockholders -119.33M-126.61M-1830.05M-2104.93M-892.87M-547.03M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 5.39M37.17M48.50M52.96M57.48M
Shares Outstanding (Diluted Average) 1149.00M1274.77M1360.37M42.00M48.61M51.89M
EBITDA -71.60M-137.03M-1838.36M-2107.29M-888.75M-550.32M
Tax Rate 0.08%0.71%0.01%0.09%